Literature DB >> 11153614

Comparison of epinephrine and vasopressin in a pediatric porcine model of asphyxial cardiac arrest.

W G Voelckel1, K G Lurie, S McKnite, T Zielinski, P Lindstrom, C Peterson, A C Krismer, K H Lindner, V Wenzel.   

Abstract

OBJECTIVE: This study was designed to compare the effects of vasopressin vs. epinephrine vs. the combination of epinephrine with vasopressin on vital organ blood flow and return of spontaneous circulation in a pediatric porcine model of asphyxial arrest.
DESIGN: Prospective, randomized laboratory investigation using an established porcine model for measurement of hemodynamic variables, organ blood flow, blood gases, and return of spontaneous circulation.
SETTING: University hospital laboratory.
SUBJECTS: Eighteen piglets weighing 8-11 kg.
INTERVENTIONS: Asphyxial cardiac arrest was induced by clamping the endotracheal tube. After 8 mins of cardiac arrest and 8 mins of cardiopulmonary resuscitation, a bolus dose of either 0.8 units/kg vasopressin (n = 6), 200 microg/kg epinephrine (n = 6), or a combination of 45 microg/kg epinephrine with 0.8 units/kg vasopressin (n = 6) was administered in a randomized manner. Defibrillation was attempted 6 mins after drug administration.
MEASUREMENTS AND MAIN RESULTS: Mean +/- SEM coronary perfusion pressure, before and 2 mins after drug administration, was 13 +/- 2 and 23 +/- 6 mm Hg in the vasopressin group; 14 +/- 2 and 31 +/- 4 mm Hg in the epinephrine group; and 13 +/- 1 and 33 +/- 6 mm Hg in the epinephrine-vasopressin group, respectively (p = NS). At the same time points, mean +/- SEM left ventricular myocardial blood flow was 44 +/- 31 and 44 +/- 25 mL x min-(1) x 100 g(-1) in the vasopressin group; 30 +/- 18 and 233 +/- 61 mL x min(-1) x 100 g(-1) in the epinephrine group; and 36 +/- 10 and 142 +/- 57 mL x min(-1) x 100 g(-1) in the epinephrine-vasopressin group (p < .01 epinephrine vs. vasopressin; p < .02 epinephrine-vasopressin vs. vasopressin). Total cerebral blood flow trended toward higher values after epinephrine-vasopressin (60 +/- 19 mL x min(-1) x 100 g(-1)) than after vasopressin (36 +/- 17 mL x min(-1) x 100 g(-1)) or epinephrine alone (31 +/- 7 mL x min(-1) x 100 g(-1); p = .07, respectively). One of six vasopressin, six of six epinephrine, and four of six epinephrine-vasopressin-treated animals had return of spontaneous circulation (p < .01, vasopressin vs. epinephrine).
CONCLUSIONS: Administration of epinephrine, either alone or in combination with vasopressin, significantly improved left ventricular myocardial blood flow during cardiopulmonary resuscitation. Return of spontaneous circulation was significantly more likely in epinephrine-treated pigs than in animals resuscitated with vasopressin alone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11153614     DOI: 10.1097/00003246-200012000-00001

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  10 in total

Review 1.  Modeling cardiac arrest and resuscitation in the domestic pig.

Authors:  Brandon H Cherry; Anh Q Nguyen; Roger A Hollrah; Albert H Olivencia-Yurvati; Robert T Mallet
Journal:  World J Crit Care Med       Date:  2015-02-04

2.  Terlipressin versus adrenaline in an infant animal model of asphyxial cardiac arrest.

Authors:  Jesús López-Herce; Bárbara Fernández; Javier Urbano; Santiago Mencía; Maria J Solana; Jimena del Castillo; Antonio Rodríguez-Núñez; Jose M Bellón
Journal:  Intensive Care Med       Date:  2010-03-18       Impact factor: 17.440

Review 3. 

Authors:  J P Nolan; C D Deakin; J Soar; B W Böttiger; G Smith; M Baubin; B Dirks; V Wenzel
Journal:  Notf Rett Med       Date:  2006-02-01       Impact factor: 0.826

4.  Lipid emulsion combined with epinephrine and vasopressin does not improve survival in a swine model of bupivacaine-induced cardiac arrest.

Authors:  Shawn D Hicks; David D Salcido; Eric S Logue; Brian P Suffoletto; Philip E Empey; Samuel M Poloyac; Donald R Miller; Clifton W Callaway; James J Menegazzi
Journal:  Anesthesiology       Date:  2009-07       Impact factor: 7.892

Review 5.  Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.

Authors:  Joshua C Reynolds; Jon C Rittenberger; James J Menegazzi
Journal:  Resuscitation       Date:  2007-03-13       Impact factor: 5.262

Review 6.  Arginine vasopressin receptor signaling and functional outcomes in heart failure.

Authors:  Melissa A Wasilewski; Valerie D Myers; Fabio A Recchia; Arthur M Feldman; Douglas G Tilley
Journal:  Cell Signal       Date:  2015-07-30       Impact factor: 4.315

7.  β-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling.

Authors:  Douglas G Tilley; Weizhong Zhu; Valerie D Myers; Larry A Barr; Erhe Gao; Xue Li; Jianliang Song; Rhonda L Carter; Catherine A Makarewich; Daohai Yu; Constantine D Troupes; Laurel A Grisanti; Ryan C Coleman; Walter J Koch; Steven R Houser; Joseph Y Cheung; Arthur M Feldman
Journal:  Circulation       Date:  2014-09-09       Impact factor: 29.690

Review 8.  Brain resuscitation in the drowning victim.

Authors:  Alexis A Topjian; Robert A Berg; Joost J L M Bierens; Christine M Branche; Robert S Clark; Hans Friberg; Cornelia W E Hoedemaekers; Michael Holzer; Laurence M Katz; Johannes T A Knape; Patrick M Kochanek; Vinay Nadkarni; Johannes G van der Hoeven; David S Warner
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

9.  The physiologic response to rescue therapy with vasopressin versus epinephrine during experimental pediatric cardiac arrest.

Authors:  Julia C Slovis; Ryan W Morgan; William P Landis; Anna L Roberts; Alexandra M Marquez; Constantine D Mavroudis; Yuxi Lin; Tiffany Ko; Vinay M Nadkarni; Robert A Berg; Robert M Sutton; Todd J Kilbaugh
Journal:  Resusc Plus       Date:  2020-11-25

10.  A comparison of combination dopamine and epinephrine treatment with high-dose dopamine alone in asphyxiated newborn piglets after resuscitation.

Authors:  Namdar Manouchehri; David L Bigam; Thomas Churchill; David Rayner; Chloe Joynt; Po-Yin Cheung
Journal:  Pediatr Res       Date:  2013-01-23       Impact factor: 3.756

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.